To read about and register for INCBCN 2023 please click here: https://academicmedicaleducation.com/meeting/innovations-nafld-care-workshop-2023

Topics
Meeting category
Date(s)
6 May 2022 - 7 May 2022
Location
Barcelona,
Spain
Meeting type
Hybrid Workshop
Organizer

Innovations in NAFLD Care Workshop 2022
Related Enduring Materials
Enduring Materials
Innovations in NAFLD Care Workshop (INCBCN) 2023
Virtual Program Book INCBCN 2022
Program
Day 1 - Friday, 6 May 2022
Session 1: NAFLD - Epidemiology and Disease Burden; Measuring a Silent Condition -
Chairs
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Is NAFLD/NASH a Public Health Challenge in 2022?
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
The Global NASH Council / Beatty Liver and Obesity Research, Inova Health System, United States
The Liver-Heart Axis – Does NASH Drive Cardiovascular Disease?
Fatal Triple – Linking Obesity, Type-2 Diabetes, and NASH
Discussion
Session 2: Screening and Risk-Stratifying for NAFLD – Who and Where? -
Chairs
Clinical Care Pathways for the Risk Stratification of Patients
Use of Intelligent Liver Function Testing in General Practice
John Dillon, MB,BS,MD,MRCP(UK),FRCP(Edinburgh)
University of Dundee / Ninewells Hospital, United Kingdom
Why and How to Identify NAFLD in Primary Care?
Discussion
Session 3: How to Manage Patients with NAFLD in Different Healthcare Facilities -
Chairs
John Dillon, MB,BS,MD,MRCP(UK),FRCP(Edinburgh)
University of Dundee / Ninewells Hospital, United Kingdom
The Central Role of Primary Care in the NASH Epidemic: Opportunities and Challenges
Nutritionists Perspective: Lifestyle and Behavioral Structured Interventions
Pushing for Weight Management: Bariatric Interventions Benefits and Considerations
Discussion
Day 2 - Saturday, 7 May 2022
Patient Organization Session -
Chair
Roundtable Discussion: the NAFLD Continuum of Care
Session 4: Multidisciplinary Management of NAFLD – How to Manage Our Patients Today? -
Chairs
The Road to Comprehensive Models of Care for NAFLD - What Are the Endpoints?
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Integrating Non-Invasive Tests for NAFLD in Clinical Practice Outside the Liver Space - Which Test and at What Level?
Using the Power of Digital Innovation - Apps Transforming Weight Management
Discussion
Industry Session -
Chairs
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Roundtable Discussion: Industry Developments Advancing Comprehensive Care Models for NAFLD
Lunch
Session 5: Future Pharmacotherapeutics for NASH - Defining Mechanisms, Drug Safety and Efficacy -
Chairs
Pharmacotherapy for Obesity - Improving Body Weight and NAFLD
How to Use Diabetes Drugs for Liver Benefit in Patients with NAFLD
Liver-Directed Drugs in the Pipeline for Fibrotic NASH
Stephen Harrison, MD, FACP, FAASLD
University of Oxford / Pinnacle Clinical Research / Summit Clinical Research, United Kingdom / United States
Discussion
Session 6: Roundtable Discussion on the Public Health Roadmap to Comprehensive Care for NAFLD/NASH -
Chairs
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Exchanging and Sharing Ideas on the NAFLD/NASH Roadmap Including Social Media and Digital Transformation of Health Care
Overview
Committees
Support
Partners
Abstract
Media
Photo Gallery